Cargando…
Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
Cancer multidrug resistance (MDR) could lead to therapeutic failure of chemotherapy and radiotherapy, and has become one of the main obstacles to successful cancer treatment. Some advanced drug delivery platforms, such as inorganic nanocarriers, demonstrate a high potential for cancer theranostic to...
Autores principales: | Lin, Gan, Mi, Peng, Chu, Chengchao, Zhang, Jun, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102675/ https://www.ncbi.nlm.nih.gov/pubmed/27980988 http://dx.doi.org/10.1002/advs.201600134 |
Ejemplares similares
-
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
por: Mi, Peng
Publicado: (2020) -
Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance
por: Chu, Siwei, et al.
Publicado: (2020) -
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
por: Xing, Hang, et al.
Publicado: (2016) -
Editorial: Functionalized Nanocarriers for Theranostics
por: Leporatti, Stefano, et al.
Publicado: (2020) -
PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
por: Flores, Orielyz, et al.
Publicado: (2017)